Jessica Sprague, MD, MS; Matthew Leibowitz, MD; Melvin W. Chiu, MD, MPH
From the David Geffen School of Medicine at the University of California, Los Angeles. Drs. Sprague and Chiu are from the Division of Dermatology. Dr. Leibowitz is from the Division of Infectious Diseases, Department of Medicine.
The authors report no conflict of interest.
Correspondence: Melvin W. Chiu, MD, MPH, Division of Dermatology, Department of Medicine, David Geffen School of Medicine at UCLA, 52-121 Center for the Health Sciences, 10833 Le Conte Ave, Los Angeles, CA 90095 (mchiu@mednet.ucla.edu).
The unpredictable presentation of cutaneous M kansasii infection coupled with the variable history necessitates a high level of clinical suspicion and a low threshold for culturing lesions. Furthermore, the long duration and complexity of the antibiotic regimen and the high incidence of adverse reactions demands strict follow-up, especially given the risk for progression to disseminated disease.
